Dermata Therapeutics DRMA
NASDAQ DRMA
$1.11 0.00 (-0.45%)
At close: Oct 2, 2026 · 4:00 PM EDT

Dermata Therapeutics (DRMA) Return on Capital Employed [ROCE] (2021)

Updated

Dermata Therapeutics' Return on Capital Employed [ROCE] came in at -70.54% for Q4 2021, up 22.69 percentage points from the prior quarter.

Analysis

Dermata Therapeutics (DRMA) Return on Capital Employed [ROCE] (2021) Analysis & Trends

For FY2021, Dermata Therapeutics' Return on Capital Employed [ROCE] was -170.88%.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Procter & Gamble 334.70 Bn 290.68 Bn 10.28 Bn 22.25%
2 Colgate Palmolive 67.39 Bn 62.44 Bn 3.30 Bn 29.67%
3 Kenvue 33.10 Bn 28.72 Bn 2.30 Bn 12.57%
4 Estee Lauder Companies 32.68 Bn 20.76 Bn 2.74 Bn 5.79%
5 Kimberly Clark 31.38 Bn 28.70 Bn 1.60 Bn 23.10%
6 Church & Dwight 22.32 Bn 20.85 Bn 693.90 Mn 14.08%
7 Clorox 9.75 Bn 8.19 Bn 804.00 Mn 38.28%
8 e.l.f. Beauty 6.14 Bn 5.11 Bn 398.84 Mn 6.09%
9 Reynolds Consumer Products 4.62 Bn 4.29 Bn 245.00 Mn 12.75%
10 Dermata Therapeutics 4.42 Mn 4.42 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2021 -70.54%
Sep 30, 2021 -93.23%
API Access

Dermata Therapeutics Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=DRMA&period=max&api_key=YOUR_API_KEY